Cargando…

Population-Based Case–Control Study of Chinese Herbal Products Containing Aristolochic Acid and Urinary Tract Cancer Risk

BACKGROUND: Consumption of Chinese herbs that contain aristolochic acid (eg, Mu Tong) has been associated with an increased risk of urinary tract cancer. METHODS: We conducted a population-based case–control study in Taiwan to examine the association between prescribed Chinese herbal products that c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lai, Ming-Nan, Wang, Shuo-Meng, Chen, Pau-Chung, Chen, Ya-Yin, Wang, Jung-Der
Formato:	Texto
Lenguaje:	English
Publicado:	Oxford University Press 2010
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815723/ https://www.ncbi.nlm.nih.gov/pubmed/20026811 http://dx.doi.org/10.1093/jnci/djp467

Ejemplares similares

Increased Risk of Urinary Tract Cancer in ESRD Patients Associated with Usage of Chinese Herbal Products Suspected of Containing Aristolochic Acid
por: Wang, Shuo-Meng, et al.
Publicado: (2014)

Chinese Herbs Containing Aristolochic Acid Associated with Renal Failure and Urothelial Carcinoma: A Review from Epidemiologic Observations to Causal Inference
por: Yang, Hsiao-Yu, et al.
Publicado: (2014)

Assessment of nephrotoxicity of herbal medicine containing aristolochic acid in mice
por: Quan, Yi, et al.
Publicado: (2020)

Reduction in the Incidence of Urological Cancers after the Ban on Chinese Herbal Products Containing Aristolochic Acid: An Interrupted Time-Series Analysis
por: Jhuang, Jing-Rong, et al.
Publicado: (2019)

Latency period of aristolochic acid-induced upper urinary tract urothelial carcinoma
por: Jhuang, Jing-Rong, et al.
Publicado: (2023)

Prescription profile of potentially aristolochic acid containing Chinese herbal products: an analysis of National Health Insurance data in Taiwan between 1997 and 2003
por: Hsieh, Shu-Ching, et al.
Publicado: (2008)

Concurrent Use of Conventional Drugs with Chinese Herbal Products in Taiwan: A Population-based Study
por: Chen, Ming-Chen, et al.
Publicado: (2013)

Risk of Liver Injury Associated with Chinese Herbal Products Containing Radix bupleuri in 639,779 Patients with Hepatitis B Virus Infection
por: Lee, Chang-Hsing, et al.
Publicado: (2011)

New Users of Herbal Medicine Containing Aristolochic Acids and the Risk of Dementia in the Elderly: A Nationwide, Population-Based Study in Taiwan
por: Chiou, Yueh-Er, et al.
Publicado: (2020)

Recent developments in detoxication techniques for aristolochic acid-containing traditional Chinese medicines
por: Fan, Yang, et al.
Publicado: (2020)

Molecular profiles and urinary biomarkers of upper tract urothelial carcinomas associated with aristolochic acid exposure
por: Karanović, Sandra, et al.
Publicado: (2021)

Increased Upper and Lower Tract Urothelial Carcinoma in Patients with End-Stage Renal Disease: A Nationwide Cohort Study in Taiwan during 1997–2008
por: Wang, Shuo-Meng, et al.
Publicado: (2014)

Aristolochic acid-associated urinary tract cancers: an updated meta-analysis of risk and oncologic outcomes after surgery and systematic review of molecular alterations observed in human studies
por: Kang, Yu-Chan, et al.
Publicado: (2021)

Efficacy of Chinese herbal medicine in a case of geriatric urinary tract infections with pain of episiotomy scar inflammation
por: Zhang, Chen, et al.
Publicado: (2018)

Metabolomic Analysis of Complex Chinese Remedies: Examples of Induced Nephrotoxicity in the Mouse from a Series of Remedies Containing Aristolochic Acid
por: Tsai, Dong-Ming, et al.
Publicado: (2013)

Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients
por: Xiong, Gengyan, et al.
Publicado: (2018)

An integrated system for identifying the hidden assassins in traditional medicines containing aristolochic acids
por: Wu, Lan, et al.
Publicado: (2015)

Aristolochic Acid Affects Upper Tract Urothelial Cancer Behavior through the MAPK Pathway
por: Chen, I-Hsuan, et al.
Publicado: (2019)

Aristolochic Acid-Induced Genotoxicity and Toxicogenomic Changes in Rodents
por: Li, Xi-Lin, et al.
Publicado: (2020)

Rare Occurrence of Aristolochic Acid Mutational Signatures in Oro-Gastrointestinal Tract Cancers
por: Lim, Abner Herbert, et al.
Publicado: (2022)

Toward clinical understanding of aristolochic acid upper-tract urothelial carcinoma
por: Boot, Arnoud, et al.
Publicado: (2020)

Increased Mortality Risk for Cancers of the Kidney  and Other Urinary Organs among Chinese Herbalists
por: Yang, Hsiao-Yu, et al.
Publicado: (2009)

Nephroprotective Role of Resveratrol and Ursolic Acid in Aristolochic Acid Intoxicated Zebrafish
por: Ding, Yu-Ju, et al.
Publicado: (2015)

Non-aristolochic acid prescribed Chinese herbal medicines and the risk of mortality in patients with chronic kidney disease: results from a population-based follow-up study
por: Hsieh, Chuan Fa, et al.
Publicado: (2014)

The role of herbal medicines in treatment of urinary tract diseases
por: Gohari, Ahmad-Reza, et al.
Publicado: (2014)

QuEChERS pretreatment combined with high-performance liquid chromatography-tandem mass spectrometry for determination of aristolochic acids I and II in Chinese herbal patent medicines
por: Zhang, Jinghe, et al.
Publicado: (2020)

Update of aristolochic acid nephropathy in Korea
por: Ban, Tae Hyun, et al.
Publicado: (2018)

Prescription profile of Chinese herbal products containing coumestrol, genestein, and/or daidzein among female users: an analysis of national health insurance data in Taiwan between 1997 and 2007
por: Wu, Chien-Tung, et al.
Publicado: (2012)

Aristolochic acid I exposure decreases oocyte quality
por: Li, Weidong, et al.
Publicado: (2022)

Correction: QuEChERS pretreatment combined with high-performance liquid chromatography-tandem mass spectrometry for determination of aristolochic acids I and II in Chinese herbal patent medicines
por: Zhang, Jinghe, et al.
Publicado: (2020)

Differential microRNA expression in aristolochic acid-induced upper urothelial tract cancers ex vivo
por: TAO, LE, et al.
Publicado: (2015)

Clinicopathologic characteristics and prognosis of upper tract urothelial carcinoma complicated with aristolochic acid nephropathy after radical nephroureterectomy
por: Shan, Hongli, et al.
Publicado: (2020)

Lynch syndrome and exposure to aristolochic acid in upper-tract urothelial carcinoma: its clinical impact?
por: Colin, Pierre, et al.
Publicado: (2016)

Aristolochic acid mutational signature defines the low-risk subtype in upper tract urothelial carcinoma
por: Lu, Huan, et al.
Publicado: (2020)

Pharmacokinetics of p-Aminohippuric Acid and Inulin in Rabbits with Aristolochic Acid Nephropathy
por: Tseng, Chiao-Shih, et al.
Publicado: (2011)

Prescription Patterns of Chinese Herbal Products for Osteoporosis in Taiwan: A Population-Based Study
por: Shih, Wei-Tai, et al.
Publicado: (2012)

Quantitative Determination and Toxicity Evaluation of Aristolochic Acid Analogues in Asarum heterotropoides F. Schmidt (Xixin) and Traditional Chinese Patent Medicines
por: Liu, Suyan, et al.
Publicado: (2021)

Overview of aristolochic acid nephropathy: an update
por: Zhou, Qingqing, et al.
Publicado: (2023)

Aristolochic acids exposure was not the main cause of liver tumorigenesis in adulthood
por: Chen, Shuzhen, et al.
Publicado: (2022)

Inflammatory bowel disease: an overview of Chinese herbal medicine formula-based treatment
por: Yuan, Shuo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n0idbrj39c909cabhacu6mgfdh